AN2 Therapeutics EV to Revenues Trends

AN2 Therapeutics Inc (ANTX)

1.26 -0.01 (-0.79%) USD | NASDAQ | Dec 20, 16:00

1.265 0.00 (0.00%) After-Hours: 20:00

View EV to Revenues for ANTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EV to Revenues Chart

Start Trial

View Historical Data

Start Trial

View EV to Revenues Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EV to Revenues Benchmarks

Start Trial

Biomarin Pharmaceutical Inc	Upgrade
Arbutus Biopharma Corp	Upgrade
GlycoMimetics Inc	--
FibroGen Inc	Upgrade
Cidara Therapeutics Inc	Upgrade

Upgrade